The pharmaceutical landscape is experiencing a change with the emergence of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to providing glucagon-like peptide-1 https://jaysonhytd359585.csublogs.com/48772675/glp-1-patches-a-novel-way-to-manage-the-condition